ASG 5ME

News alerts, weekly reports and conference planners

Company:

Pfizer

Drug class:

Microtubule inhibitor, SLC44A4-targeted antibody-drug conjugate

SLC44A4 expression	Gastric Cancer	SLC44A4 expression	Gastric Cancer	ASG 5ME Sensitive: C3 – Early Trials ASG 5ME Sensitive : C3	ASG 5ME Sensitive: C3 – Early Trials ASG 5ME Sensitive : C3
SLC44A4 expression	Pancreatic Cancer	SLC44A4 expression	Pancreatic Cancer	ASG 5ME Sensitive: D – Preclinical ASG 5ME Sensitive : D	ASG 5ME Sensitive: D – Preclinical ASG 5ME Sensitive : D
SLC44A4 expression	Prostate Cancer	SLC44A4 expression	Prostate Cancer	ASG 5ME Sensitive: D – Preclinical ASG 5ME Sensitive : D	ASG 5ME Sensitive: D – Preclinical ASG 5ME Sensitive : D

Associations
(3)